1. The efficacy of Chinese herbal medicine as an adjunctive therapy for colorectal cancer: A systematic review and meta-analysis 
Linda L.D. Zhong, Hai-Yong Chen, William C.S. Cho, Xiao-ming Meng, Yao Tong 
Complementary Therapies in Medicine 
Volume 20, Issue 4, Pages (August 2012)
DOI: /j.ctim
Copyright © 2012 Elsevier Ltd Terms and Conditions

2. Figure 1
Flow diagram of study selection. CHM: Chinese herbal medicine.
Complementary Therapies in Medicine  , DOI: ( /j.ctim )
Copyright © 2012 Elsevier Ltd Terms and Conditions

3. Figure 2
Overall survival estimated from meta-analysis of pairwise comparisons in patients with Chinese herbal medicine (CHM, treatment group) versus patients without CHM (control group): (A) number of patients with survival >1 year; (B) number of patients with survival >3 years.
Complementary Therapies in Medicine  , DOI: ( /j.ctim )
Copyright © 2012 Elsevier Ltd Terms and Conditions

4. Figure 3
Overall efficacy estimated from meta-analysis of pairwise comparisons in patients with Chinese herbal medicine (CHM, treatment group) versus patients without CHM (control group): (A) number of patients with complete response (CR) or partial response (PR); (B) number of patients with progressive disease (PD); (C) number of patients with non-deterioration Karnofsky performance score (KPS).
Complementary Therapies in Medicine  , DOI: ( /j.ctim )
Copyright © 2012 Elsevier Ltd Terms and Conditions

5. Figure 4
Immune effect estimated from meta-analysis of pairwise comparisons in patients with Chinese herbal medicine (CHM, treatment group) versus patients without CHM (control group): (A) mean difference between pre- and post-treatment CD3 T cell levels of patients treated by FOLFOX; (B) mean difference between pre- and post-treatment CD4 T cell levels of patients treated by chemotherapy (CMT); (C) mean difference between pre- and post-treatment CD4/CD8 ratios of patients treated by chemotherapy (CMT).
Complementary Therapies in Medicine  , DOI: ( /j.ctim )
Copyright © 2012 Elsevier Ltd Terms and Conditions

6. Figure 5
Reduction of adverse effects estimated from meta-analysis of pairwise comparisons in patients with Chinese herbal medicine (CHM, treatment group) versus patients without CHM (control group): (A) number of patients with nausea and vomiting treated by 5-FU/CF; (B) number of patients with appetite loss treated by chemotherapy (CMT); (C) number of patients with diarrhea treated by FOLFOX or 5-FU/CF.
Complementary Therapies in Medicine  , DOI: ( /j.ctim )
Copyright © 2012 Elsevier Ltd Terms and Conditions